Loading...

Akebia Therapeutics, Inc.

AKBA•NASDAQ
Healthcare
Biotechnology
$3.56
$-0.28(-7.29%)

Akebia Therapeutics, Inc. (AKBA) Stock Chart & Performance Analysis

Explore Akebia Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-8.82%
5-Day Change
-15.30%
1-Month Change
-16.67%
3-Month Change
-11.43%
6-Month Change
21.09%
Year-to-Date (YTD) Change
-18.42%
1-Year Change
-0.64%
3-Year Change
203.33%
5-Year Change
-77.54%
All-Time (Max) Change
-94.19%

Analyzing Akebia Therapeutics, Inc. (AKBA) Trends Across Multiple Time Frames

Akebia Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Akebia Therapeutics, Inc. stock shows -8.82% 1-day change, indicating low volatility, while its 5-day change of -15.30% suggests a broader trend. Over a 1-month period, a -16.67% drop could signal a pullback, whereas a 3-month decline of -11.43% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 21.09% and a YTD drop of -18.42% might concern investors, but a 1-year loss of -0.64% and a 3-year increase of 203.33% could indicate resilience. The 5-year surge of -77.54% highlights weak historical growth, while the all-time return of -94.19% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;